Report Details

Global (North America, Asia Pacific, Europe, Middle East, Africa, LATAM) Hospital-acquired infections (HAIs) Control Market Trend, Forecast to 2028

Global (North America, Asia Pacific, Europe, Middle East, Africa, LATAM) Hospital-acquired infections (HAIs) Control Market Trend, Forecast to 2028

Report Format PDF & Excel
Pages 94
Publish Date Mar, 2018

This report studies the global Hospital-acquired infections (HAIs) Control market, analyzes and researches the Hospital-acquired infections (HAIs) Control development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

STERIS Corporation

Advanced Sterilization Products Division

Hoffmann-La Roche

Pfizer

Becton Dickinson



Market segment by Regions/Countries, this report covers

United States

EU

Japan

China

India

Southeast Asia


Market segment by Type, the product can be split into

Diagnostic techniques

Dleaning and sterilization

Treatment


Market segment by Application, Hospital-acquired infections (HAIs) Control can be split into

General Hospital

Infectious Disease Hospital


If you have any special requirements, please let us know and we will offer you the report as you want.



Global Hospital-acquired infections (HAIs) Control Market Size, Status and Forecast 2025

1 Industry Overview of Hospital-acquired infections (HAIs) Control

1.1 Hospital-acquired infections (HAIs) Control Market Overview

1.1.1 Hospital-acquired infections (HAIs) Control Product Scope

1.1.2 Market Status and Outlook

1.2 Global Hospital-acquired infections (HAIs) Control Market Size and Analysis by Regions (2013-2018)

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Hospital-acquired infections (HAIs) Control Market by Type

1.3.1 Diagnostic techniques

1.3.2 Dleaning and sterilization

1.3.3 Treatment

1.4 Hospital-acquired infections (HAIs) Control Market by End Users/Application

1.4.1 General Hospital

1.4.2 Infectious Disease Hospital

2 Global Hospital-acquired infections (HAIs) Control Competition Analysis by Players

2.1 Hospital-acquired infections (HAIs) Control Market Size (Value) by Players (2013-2018)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 STERIS Corporation

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Hospital-acquired infections (HAIs) Control Revenue (Million USD) (2013-2018)

3.1.5 Recent Developments

3.2 Advanced Sterilization Products Division

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Hospital-acquired infections (HAIs) Control Revenue (Million USD) (2013-2018)

3.2.5 Recent Developments

3.3 Hoffmann-La Roche

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Hospital-acquired infections (HAIs) Control Revenue (Million USD) (2013-2018)

3.3.5 Recent Developments

3.4 Pfizer

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Hospital-acquired infections (HAIs) Control Revenue (Million USD) (2013-2018)

3.4.5 Recent Developments

3.5 Becton Dickinson

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Hospital-acquired infections (HAIs) Control Revenue (Million USD) (2013-2018)

3.5.5 Recent Developments

4 Global Hospital-acquired infections (HAIs) Control Market Size by Type and Application (2013-2018)

4.1 Global Hospital-acquired infections (HAIs) Control Market Size by Type (2013-2018)

4.2 Global Hospital-acquired infections (HAIs) Control Market Size by Application (2013-2018)

4.3 Potential Application of Hospital-acquired infections (HAIs) Control in Future

4.4 Top Consumer/End Users of Hospital-acquired infections (HAIs) Control

5 United States Hospital-acquired infections (HAIs) Control Development Status and Outlook

5.1 United States Hospital-acquired infections (HAIs) Control Market Size (2013-2018)

5.2 United States Hospital-acquired infections (HAIs) Control Market Size and Market Share by Players (2013-2018)

5.3 United States Hospital-acquired infections (HAIs) Control Market Size by Application (2013-2018)

6 EU Hospital-acquired infections (HAIs) Control Development Status and Outlook

6.1 EU Hospital-acquired infections (HAIs) Control Market Size (2013-2018)

6.2 EU Hospital-acquired infections (HAIs) Control Market Size and Market Share by Players (2013-2018)

6.3 EU Hospital-acquired infections (HAIs) Control Market Size by Application (2013-2018)

7 Japan Hospital-acquired infections (HAIs) Control Development Status and Outlook

7.1 Japan Hospital-acquired infections (HAIs) Control Market Size (2013-2018)

7.2 Japan Hospital-acquired infections (HAIs) Control Market Size and Market Share by Players (2013-2018)

7.3 Japan Hospital-acquired infections (HAIs) Control Market Size by Application (2013-2018)

8 China Hospital-acquired infections (HAIs) Control Development Status and Outlook

8.1 China Hospital-acquired infections (HAIs) Control Market Size (2013-2018)

8.2 China Hospital-acquired infections (HAIs) Control Market Size and Market Share by Players (2013-2018)

8.3 China Hospital-acquired infections (HAIs) Control Market Size by Application (2013-2018)

9 India Hospital-acquired infections (HAIs) Control Development Status and Outlook

9.1 India Hospital-acquired infections (HAIs) Control Market Size (2013-2018)

9.2 India Hospital-acquired infections (HAIs) Control Market Size and Market Share by Players (2013-2018)

9.3 India Hospital-acquired infections (HAIs) Control Market Size by Application (2013-2018)

10 Southeast Asia Hospital-acquired infections (HAIs) Control Development Status and Outlook

10.1 Southeast Asia Hospital-acquired infections (HAIs) Control Market Size (2013-2018)

10.2 Southeast Asia Hospital-acquired infections (HAIs) Control Market Size and Market Share by Players (2013-2018)

10.3 Southeast Asia Hospital-acquired infections (HAIs) Control Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)

11.1 Global Hospital-acquired infections (HAIs) Control Market Size (Value) by Regions (2018-2025)

11.1.1 United States Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2018-2025)

11.1.2 EU Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2018-2025)

11.1.3 Japan Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2018-2025)

11.1.4 China Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2018-2025)

11.1.5 India Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2018-2025)

11.1.6 Southeast Asia Hospital-acquired infections (HAIs) Control Revenue and Growth Rate (2018-2025)

11.2 Global Hospital-acquired infections (HAIs) Control Market Size (Value) by Type (2018-2025)

11.3 Global Hospital-acquired infections (HAIs) Control Market Size by Application (2018-2025)

12 Hospital-acquired infections (HAIs) Control Market Dynamics

12.1 Hospital-acquired infections (HAIs) Control Market Opportunities

12.2 Hospital-acquired infections (HAIs) Control Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Hospital-acquired infections (HAIs) Control Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Hospital-acquired infections (HAIs) Control Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

Research Methodology
The research study released with title "Global (North America, Asia Pacific, Europe, Middle East, Africa, LATAM) Hospital-acquired infections (HAIs) Control Market Trend, Forecast to 2028" involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Key Executives Interviewed

Global Hospital acquired infections review

Research Programs/Design
Historical Data (2017-2022E)
  • Industry Trends
  • Competition Analysis & Landscape
  • By Company
  • Product Launches
  • Joint Venture & Partnerships
  • Merger & Acquisitions
  • Market Segment
  • by Type
  • by Application / End Users
  • By Regions/ Geography
  • Value in Dollar Term
  • Segment Revenue for Major & Emerging Players
  • Market Share
  • % Growth Rate
  • Current Scenario Analysis
  • Sales Volume by Key Players
  • % Market Share & Position
  • % Growth Rate
Market Factor Analysis
  • Market Environment
  • Government Policy & Regulatory Factors
  • Technological Changes
  • Market Risks & Challenges
  • Market Drivers
  • Market Maturity Indicators
  • Impact of Cost Variance
  • Growth Determinants
Market Forecast (2023F-2028F)
  • Overall Size (Value & Volume*)
  • by Type
  • by Application
  • By Region / Country
  • Key Data (Value & Volume*)
  • %Market Share
  • %Growth Rate
  • CAGR (2023-2028)

Market Size Estimation

Top-down and bottom-up approaches are used to validate and estimate the global/regional market size by manufacturers, regional splits, product segments and application.

To establish Research coverage of the study with most relevant & functional players HTF MI follows industry standards such as NAICS/SIC/ICB/TRCB, furthermore the sorted list of companies is validated using Product Mapping and business activities and shortlisted by industry perspective.

HTF MI select experienced analyst and associate that are specialized in the domain for conducting research. They prepare a list of companies by region that helps to understand players penetration rate in the market. This companies are further analyses in what segment or application they serve in our market. The list of product and applications are evaluated for each companies dealing in the Global Hospital acquired infections review. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global. Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Online) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc from Global Hospital acquired infections review who then work towards appointment generation.

Primary Data Collection

The primary research is performed by taking the interviews of executives of various companies dealing in the Global Hospital acquired infections review as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and relevant list of appointee or target primary respondents; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & In Mail, Community Forums, Open Survey, SurveyMonkey etc.

Secondary Sources

The secondary resources considered in the Global Hospital acquired infections review study includes company annual reports, press releases, published articles of organizations and associations, and the survey taken through different mediums such as online website and forums, survey monkey, LinkedIn, etc. In addition, the valuable strategic information obtained from industry association, paid database, and investor presentations are also good tool for information to make appropriate iterative validation are used to modify market models and cross-verify primary research and insights.

Market Breakdown and Data Triangulation

To make market engineering data complete; extensive primary research is conducted to gather information and validate the critical numbers derived to be used for calculations of market statistics; market size estimations; forecasting; breakdown; and data triangulation. Both top-down and bottom-up approaches were applied, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Furthermore qualitative and further quantitative analysis is also done for all the numbers arrived at in the market estimation process to list relevant information in the final deliverable report "Global (North America, Asia Pacific, Europe, Middle East, Africa, LATAM) Hospital-acquired infections (HAIs) Control Market Trend, Forecast to 2028" .

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Research Journals
  • Company Websites
  • White Papers
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • HTF MI Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segment value
Qualitative Analysis
  • Influencing Trends
  • Market Potential
  • Market Risks and Opportunities
  • Growth Drivers and Constraints
  • Geographical Footprints
  • Government Policies
  • Company Websites and Press Releases
  • Survey Reports and Paid Databases
  • Annual Reports
  • Industry Associations
  • HTF MI Database

Key Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments
  • Market Forecast (Value & Volume*) by Application, Type & Region / Country
  • History and Forecast
  • Market Size (Value & Volume) by Application
  • Market Size by Regions, Status & Forecast
  • Market Share & Growth Rate by Type & Application
  • Value by Key Business Segments
  • % Growth Rate by Segments
  • Growth Rate and Market Share by Regions
  • Market Size Status & Forecast
Total Market
  • Overall Size, Status & Forecast
  • Market Size Status & Forecast
Format Properties
1-User Access The report is sent in PDF format. The report will be emailed to you. This is a single user access license, allowing one specific user to access the report.
Site User The study would be provided in PDF format. The report will be emailed to you. This is a site license, allowing 1-10 employees within your organisation to access the report.
Enterprise User The format of deliverable would be PDF and Excel. This is an enterprise or corporate license, allowing all employees within your organisation irrespective of geographic location to access the report.

Frequently Asked Questions (FAQ):

As manufacturers prepare to scale up, ( Asia Pacific LATAM) Hospital acquired infections (HAIs) Control companies also need to be transparent about how volatility is impacting the balance sheet.
The ( Asia Pacific LATAM) Hospital acquired infections (HAIs) Control industry stakeholders, executives and experts and individuals who need to develop strategies to appeal to consumers and leverage technology to outpace market competition.
The ( Asia Pacific LATAM) Hospital acquired infections (HAIs) Control market is expected to record a substantial market valuation.